dBRD9

CAS No. 2170679-45-3

dBRD9( dBRD 9 )

Catalog No. M13465 CAS No. 2170679-45-3

dBRD9 is a PROTAC that bridge the BRD9 bromodomain and the cereblon E3 ubiquitin ligase complex.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 434 In Stock
5MG 312 In Stock
10MG 502 In Stock
25MG 874 In Stock
50MG 1293 In Stock
100MG 1795 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    dBRD9
  • Note
    Research use only, not for human use.
  • Brief Description
    dBRD9 is a PROTAC that bridge the BRD9 bromodomain and the cereblon E3 ubiquitin ligase complex.
  • Description
    dBRD9 is a PROTAC that bridge the BRD9 bromodomain and the cereblon E3 ubiquitin ligase complex; exhibits markedly enhanced potency compared to parental ligands (10-100 fold).
  • In Vitro
    Western Blot Analysis Cell Line:MOLM-13 cells.Concentration:0.5, 5, 50, 500 and 5000 nM.Incubation Time:4 h.Result:Reduced the expression of BRD9.
  • In Vivo
    ——
  • Synonyms
    dBRD 9
  • Pathway
    PROTACs
  • Target
    PROTAC
  • Recptor
    PROTAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2170679-45-3
  • Formula Weight
    783.839
  • Molecular Formula
    C40H45N7O10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (127.58 mM)
  • SMILES
    O=C(NCCOCCOCCNC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O)CN(CC4=C(OC)C=C(C(C5=CC=NC=C65)=CN(C)C6=O)C=C4OC)C
  • Chemical Name
    2-((2,6-dimethoxy-4-(2-methyl-1-oxo-1,2-dihydro-2,7-naphthyridin-4-yl)benzyl)(methyl)amino)-N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Remillard D, et al. Angew Chem Int Ed Engl. 2017 May 15;56(21):5738-5743.
molnova catalog
related products
  • GSK983

    GSK983 (GSK-983) is a potent, cell penetrant PCAF/GCN5 PROTAC, induces concentration-dependent degradation of PCAF and GCN5 in THP1 cells with DC50 value of 1.5 nM and 3 nM, respectively.

  • PAC

    PAC1 (Compound PAC1) is a novel PROTAC antibody conjugate, more potent estrogen receptor-alpha (ERα) degrader compared to PROTAC without antibody conjugation.

  • m-PEG11-Br

    m-PEG11-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.